Lenalidomide in Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma (NHL) in adults. Even if the natural history of DLBCL has been improved with the advent of immunochemotherapy, the survival results obtained with current treatment options clearly indicate that new agents or...

Descripción completa

Detalles Bibliográficos
Autores principales: Thieblemont, Catherine, Delfau-Larue, Marie-Hélène, Coiffier, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508519/
https://www.ncbi.nlm.nih.gov/pubmed/23251161
http://dx.doi.org/10.1155/2012/861060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508519/
https://www.ncbi.nlm.nih.gov/pubmed/23251161
http://dx.doi.org/10.1155/2012/861060

Ejemplares similares